164
Views
5
CrossRef citations to date
0
Altmetric
Review

Predictors of adverse outcomes after transcatheter mitral valve replacement

, , &
Pages 625-632 | Received 08 Jul 2019, Accepted 05 Aug 2019, Published online: 14 Aug 2019

References

  • Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368:1005–1011.
  • Bridgewater B, Kinsman R, Walton P, et al. The 4th European association for cardio-thoracic surgery adult cardiac surgery database report. Interact Cardiovasc Thorac Surg. 2011;12:4–5.
  • Nishimura RA, Otto CM, Bonow RO, et al. AHA/ACC guideline for the management of patients with valvular heart diseasea report of the American college of cardiology/american heart association task force on practice guidelines. J Am Coll Cardiol. 2014;63:e57–e185.
  • Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012)the joint task force on the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2012;33:2451–2496.
  • Dziadzko V, Clavel M-A, Dziadzko M, et al. Outcome and undertreatment of mitral regurgitation: a community cohort study. Lancet. 2018;391:960–969.
  • Mack MJ, Leon MB, Thourani VH, et al. Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients. N. Engl. J. Med. 2019;380:1695–1705.
  • Siontis GCM, Overtchouk P, Cahill TJ, et al. Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis. Eur Heart J [Internet]. [cited 2019 May 10]. Available from: https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehz275/5477387.
  • Popma JJ, Deeb GM, Yakubov SJ. et al. Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients. N. Engl. J. Med. 2019;380:1706–1715.
  • Fann JI, Goar FGS, Komtebedde J, et al. Beating heart catheter-based edge-to-edge mitral valve procedure in a porcine model: efficacy and healing response. Circulation. 2004;110:988–993.
  • Chikwe J, Goldstone AB, Passage J, et al. A propensity score-adjusted retrospective comparison of early and mid-term results of mitral valve repair versus replacement in octogenarians. Eur Heart J. 2011;32:618–626.
  • Gillinov AM, Cosgrove DM, Blackstone EH, et al. Durability of mitral valve repair for degenerative disease. J Thorac Cardiovasc Surg. 1998;116:734–743.
  • McCarthy KP, Ring L, Rana BS. Anatomy of the mitral valve: understanding the mitral valve complex in mitral regurgitation. Eur J Echocardiogr J Work Group Echocardiogr Eur Soc Cardiol. 2010;11:i3–9.
  • Søndergaard L, De Backer O, Franzen OW, et al. First-in-human case of transfemoral cardiAQ mitral valve implantation. Circ Cardiovasc Interv. 2015;8:e002135.
  • Bapat V, Rajagopal V, Meduri C, et al. Early experience with new transcatheter mitral valve replacement. J Am Coll Cardiol. 2018;71:12–21.
  • Muller DWM, Farivar RS, Jansz P, et al. Transcatheter mitral valve replacement for patients with symptomatic mitral regurgitation: a global feasibility trial. J Am Coll Cardiol. 2017;69:381–391.
  • Sorajja P, Moat N, Badhwar V, et al. Initial feasibility study of a new transcatheter mitral prosthesis: the first 100 patients. J Am Coll Cardiol. 2019;73:1250–1260.
  • Lim DS, Kar S, Spargias K et al. Citation: Transcatheter Valve Repair for Patients With Mitral Regurgitation: 30-Day Results of the CLASP Study. JACC Cardiovasc Interv 2019. [Epub ahead of print].
  • Webb JG, Murdoch DJ, Boone RH, et al. Percutaneous transcatheter mitral valve replacement: first-in-human experience with a new transseptal system. J Am Coll Cardiol. 2019;73:1239–1246.
  • Yoon S-H, Whisenant BK, Bleiziffer S, et al. Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification. Eur Heart J. 2019;40:441–451.
  • Okada Y. Surgical management of mitral annular calcification. Gen Thorac Cardiovasc Surg. 2013;61:619–625.
  • Eng MH, Wang DD. Transseptal transcatheter mitral valve replacement for post-surgical mitral failures. J. - transseptal transcatheter mitral valve replace. Post-Surg Mitral Fail [Internet]. 2017 [cited 2019 Jul 8]. Available from: https://www.icrjournal.com/articles/transseptal-transcatheter-mitral-valve.
  • Poulin A, Bernier M, Rodes-Cabau J, et al. Subacute mitral valve dysfunction after transcatheter aortic and mitral valve replacements. J Thorac Cardiovasc Surg. 2018;155:e167–e172.
  • Stone GW, Vahanian AS, Adams DH, et al. Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 1: clinical trial design principles: a consensus document from the mitral valve academic research consortium. J Am Coll Cardiol. 2015;66:278–307.
  • Murphy DJ, Ge Y, Don CW, et al. Use of cardiac computerized tomography to predict neo-left ventricular outflow tract obstruction before transcatheter mitral valve replacement. J Am Heart Assoc. 2017;6.
  • Wang DD, Eng MH, Greenbaum AB, et al. Validating a prediction modeling tool for left ventricular outflow tract (LVOT) obstruction after transcatheter mitral valve replacement (TMVR). Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv. 2018;92:379–387.
  • Blanke P, Naoum C, Dvir D, et al. Predicting LVOT obstruction in transcatheter mitral valve implantation: concept of the Neo-LVOT. JACC Cardiovasc Imaging. 2017;10:482–485.
  • Guerrero M, Dvir D, Himbert D, et al. Transcatheter mitral valve replacement in native mitral valve disease with severe mitral annular calcification: results from the first multicenter global registry. JACC Cardiovasc Interv. 2016;9:1361–1371.
  • Guerrero M, Urena M, Himbert D, et al. 1-year outcomes of transcatheter mitral valve replacement in patients with severe mitral annular calcification. J Am Coll Cardiol. 2018;71:1841–1853.
  • Greenbaum AB, Condado JF, Eng M, et al. Long or redundant leaflet complicating transcatheter mitral valve replacement: case vignettes that advocate for removal or reduction of the anterior mitral leaflet. Catheter Cardiovasc Interv. 2018;92:627–632.
  • Wang DD, Eng M, Greenbaum A, et al. Predicting LVOT obstruction after TMVR. JACC Cardiovasc Imaging. 2016;9:1349–1352.
  • Guerrero M, Wang DD, Himbert D, et al. Short-term results of alcohol septal ablation as a bail-out strategy to treat severe left ventricular outflow tract obstruction after transcatheter mitral valve replacement in patients with severe mitral annular calcification. Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv. 2017;90:1220–1226.
  • Khan JM, Trivedi U, Gomes A, et al. “Rescue” LAMPOON to treat transcatheter mitral valve replacement–associated left ventricular outflow tract obstruction. JACC Cardiovasc Interv. 2019;12:1283–1284.
  • Lisko J, Kamioka N, Gleason P, et al. Prevention and treatment of left ventricular outflow tract obstruction after transcatheter mitral valve replacement. Interv Cardiol Clin. 2019;8:279–285.
  • Wang DD, Guerrero M, Eng MH, et al. Alcohol septal ablation to prevent left ventricular outflow tract obstruction during transcatheter mitral valve replacement: first-in-man study. JACC Cardiovasc Interv. 2019;12:1268–1279.
  • Khan JM, Babaliaros VC, Greenbaum AB, et al. Anterior leaflet laceration to prevent ventricular outflow tract obstruction during transcatheter mitral valve replacement. J Am Coll Cardiol. 2019;73:2521–2534.
  • Cheung A. Early experience of TIARA transcatheter mitral valve replacement system. Ann Cardiothorac Surg. 2018;7:787–791.
  • Cheung A, Webb J, Schaefer U, et al. Transcatheter mitral valve replacement in patients with previous aortic valve replacement. Circ Cardiovasc Interv. 2018;11:e006412.
  • Barbanti M, Piazza N, Mangiafico S, et al. Transcatheter mitral valve implantation using the HighLife system. JACC Cardiovasc Interv. 2017;10:1662–1670.
  • Regueiro A, Granada JF, Dagenais F, et al. Transcatheter mitral valve replacement: insights from early clinical experience and future challenges. J Am Coll Cardiol. 2017;69:2175–2192.
  • Modine T, Overtchouk P. Catheter-based innovations in mitral valve surgery. Eur J Cardiothorac Surg [Internet]. [cited 2019 Jun 12]. Available from: https://academic.oup.com/ejcts/advance-article/doi/10.1093/ejcts/ezz164/5513230.
  • Verheye S, Cheung A, Leon M, et al. The Tiara transcatheter mitral valve implantation system. EuroIntervention J Eur Collab Work Group Interv Cardiol Eur Soc Cardiol. 2015;11(Suppl W):W71–72.
  • Hulman M, Bena M, Artemiou P, et al. Iterative learning of transcatheter mitral valve replacement in mitral valve annulus calcification: management and prevention of transcatheter mitral valve replacement dislocation. Ann Thorac Surg. 2016;102:e287–e290.
  • Dangas GD, Weitz JI, Giustino G, et al. Prosthetic Heart Valve Thrombosis. J Am Coll Cardiol. 2016;68:2670–2689.
  • Taramasso M, Maisano F. Transcatheter mitral valve interventions: pathophysiological considerations in choosing reconstruction versus transcatheter valve implantation [Internet]. EuroIntervention. [cited 2019 Jul 8]. Available from: https://eurointervention.pcronline.com/article/transcatheter-mitral-valve-interventions-pathophysiological-considerations-in-choosing-reconstruction-versus-transcatheter-valve-implantation.
  • Nishimura RA, Otto CM, Bonow RO, et al. AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the american college of cardiology/American heart association task force on clinical practice guidelines. J Am Coll Cardiol. 2017;70:252–289.
  • Baumgartner H, Falk V, Bax JJ, et al. ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2017;38:2739–2791.
  • Bapat V. Technical pitfalls and tips for the valve-in-valve procedure. Ann Cardiothorac Surg. 2017;6:541–552.
  • Nombela-Franco L, Webb JG, de Jaegere PP, et al. Timing, predictive factors, and prognostic value of cerebrovascular events in a large cohort of patients undergoing transcatheter aortic valve implantationclinical perspective. Circulation. 2012;126:3041–3053.
  • Overtchouk P, Centre Hospitalier Regional Et Universitaire de Lille, Lille, France, Modine T, et al. Alternate access for TAVI: stay clear of the chest. Interv Cardiol Rev. 2018;13:145.
  • Doshi R, Shah P, Meraj PM. In-hospital outcomes comparison of transfemoral vs transapical transcatheter aortic valve replacement in propensity-matched cohorts with severe aortic stenosis. Clin Cardiol. 2018;41:326–332.
  • Meyer CG, Frick M, Lotfi S, et al. Regional left ventricular function after transapical vs. transfemoral transcatheter aortic valve implantation analysed by cardiac magnetic resonance feature tracking. Eur Heart J - Cardiovasc Imaging. 2014;15:1168–1176.
  • Latib A, Granada JF. Experimental validation of TMVR technologies: a bumpy road with the risk of getting lost in translation [Internet]. EuroIntervention. [cited 2019 Jul 8]. Available from: https://eurointervention.pcronline.com/article/experimental-validation-of-tmvr-technologies-a-bumpy-road-with-the-risk-of-getting-lost-in-translation.
  • Wyler von Ballmoos MC, Kalra A, Reardon MJ. Complexities of transcatheter mitral valve replacement (TMVR) and why it is not transcatheter aortic valve replacement (TAVR). Ann Cardiothorac Surg. 2018;7:724–730.
  • Frerker C, Schlüter M, Sanchez OD, et al. Cerebral protection during mitraclip implantation: initial experience at 2 centers. JACC Cardiovasc Interv. 2016;9:171–179.
  • Franzen OW, Klemm H, Hamann F, et al. Mechanisms underlying air aspiration in patients undergoing left atrial catheterization. Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv. 2008;71:553–558.
  • Alkhouli M, Rihal CS, Holmes DR. Transseptal techniques for emerging structural heart interventions. JACC Cardiovasc Interv. 2016;9:2465–2480.
  • Alkhouli M, Sarraf M, Zack CJ, et al. Iatrogenic atrial septal defect following transseptal cardiac interventions. Int J Cardiol. 2016;209:142–148.
  • Alkhouli M, Sarraf M, Holmes DR. Iatrogenic atrial septal defect. Circ Cardiovasc Interv. 2016;9:e003545.
  • Une D, Ruel M, David TE. Twenty-year durability of the aortic hancock II bioprosthesis in young patients: is it durable enough? Eur. J Cardio-Thorac Surg Off J Eur Assoc Cardio-Thorac Surg. 2014;46:825–830.
  • Noorani A, Radia R, Bapat V. Challenges in valve-in-valve therapy. J Thorac Dis. 2015;7:1501–1508.
  • Duncan A, Daqa A, Yeh J, et al. Transcatheter mitral valve replacement: long-term outcomes of first-in-man experience with an apically tethered device- a case series from a single centre. EuroIntervention J Eur Collab Work Group Interv Cardiol Eur Soc Cardiol. 2017;13:e1047–e1057.
  • Dahle G, Helle-Valle T, Beitnes JO, et al. Single-centre first experience with transapical transcatheter mitral valve replacement with an apical tether: factors influencing screening outcomes. Interact Cardiovasc Thorac Surg. 2019;28:695–703.
  • Feldman T, Kar S, Elmariah S, et al. Randomized comparison of percutaneous repair and surgery for mitral regurgitation: 5-year results of EVEREST II. J Am Coll Cardiol. 2015;66:2844–2854.
  • Goldstein D, Moskowitz AJ, Gelijns AC, et al. Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation. N Engl J Med. 2016;374:344–353.
  • Acker MA, Parides MK, Perrault LP, et al. Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med. 2014;370:23–32.
  • Modine T, Overtchouk P. Mitral valve repair vs replacement in the STS database: the debate continues. Ann Thorac Surg. 2019;108:647–648.
  • Navia JL, Kapadia S, Elgharably H, et al. Transcatheter tricuspid valve implantation of navigate bioprosthesis in a preclinical model. JACC Basic Transl Sci. 2018;3:67–79.
  • Badhwar V, Thourani VH, Ailawadi G, et al. Transcatheter mitral valve therapy: The event horizon. J Thorac Cardiovasc Surg. 2016;152:330–336.
  • Regueiro A, Ye J, Fam N, et al. 2-year outcomes after transcatheter mitral valve replacement. JACC Cardiovasc Interv. 2017;10:1671–1678.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.